
Crossroads of Johnstown
Drug & Addiction Treatment • Johnstown, PA
Information from public sources; not independently verified. Confirm hours, insurance and appointment availability with the clinic.
Last gathered July 11, 2026. How our information is sourced · Report incorrect information
About
Crossroads of Johnstown is an outpatient addiction treatment clinic in Johnstown, PA offering opioid addiction treatment through medication-assisted therapy including Suboxone, Sublocade, Brixadi, and Vivitrol. The clinic provides medical and clinical assessments, care coordination, and Hepatitis C treatment services.
Services Offered
Insurance & Payment
Private pay, Medicaid, Medicare, Insurance accepted by location varies
Languages Spoken
FAQs
What services are offered at the Johnstown Suboxone Clinic?
Outpatient addiction treatment with Suboxone/medication-assisted treatment and center offerings like Care Coordination and Hepatitis C treatment.
What are the center hours?
The clinic lists various daily opening hours, with a typical range around morning to early afternoon slots (example: 7:30 AM to 3:30 PM or similar) and varying daily schedules.
Is there a 24/7 call center?
Call Center is listed as Open 24/7/365.
What is the contact phone number?
855.694.8288
What is the address for the clinic?
132 Walnut Street, 2nd Floor, Johnstown, PA 15901
Social Media
Photos
Photos published by Crossroads of Johnstown showing the drug & addiction treatment practice in Johnstown, PA.








In the News
- Crossroads Treatment Center Johnstown - Recovery.com - Aug 26, 2025
- Suboxone Treatment in PA & WV - Recover Clarity - Oct 19, 2025
- Crossroads of Butler - Butler, Pennsylvania | Detox Centers - Sep 21, 2025
- Mental health resource opens Cambria County location - Sep 3, 2025
Information sourced from the clinic's website as of July 11, 2026.
Other drug & addiction treatment clinics in Johnstown
Related articles
Comparing your options?
See other drug & addiction treatment clinics in Johnstown, or search the full directory by insurance, ratings, and more.

